search
Back to results

Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer. (AMRIS)

Primary Purpose

Massive Rotator Cuff Tears

Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Biodegradable spacer
Debridement and biceps tenotomy
Sponsored by
Oslo University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Massive Rotator Cuff Tears focused on measuring Ballon spacer, Biodegradable spacer, Subacromial spacer

Eligibility Criteria

60 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs classification.
  • Persistent pain for at least 3 months, with documented failure of conservative treatment
  • Age ranging from 60 years of age to 85 years of age

Exclusion Criteria:

  • Significant shoulder osteoarthritis in the affected shoulder, Hamada classification >2.
  • Total rupture of subscapularis tendon and/or teres minor, classified B and E in the Collins classification.
  • Comorbidity to the degree that the patient will not be able to participate in the follow up program.

Sites / Locations

  • Hospital of Southern Norway, ArendalRecruiting
  • Oslo university hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group A: Biodegradable spacer

Group B: control group

Arm Description

Intervention group

Control group

Outcomes

Primary Outcome Measures

Change in Constant score
A well review score that takes several factors in to account: active range of motion, activities of daily living, pain and strength. A person with a normal, healthy shoulder should score 100 points, which is maximum score. Constant score is seen as a relatively objective test, as the testing will be performed by a physiotherapist.

Secondary Outcome Measures

WORC
Western Ontario Rotator Cuff Index is a questionnaire that explores 5 domains: physical symptoms, sports and recreation, work, social function, emotions.
X-ray of the shoulder
Measure the height from the head of the humerus to the acromion
VAS
Visual analog scale for pain in rest, activity and at night. Scale from 0 til 10.
Eq-5D
Questionaire for daily activity

Full Information

First Posted
June 29, 2020
Last Updated
September 25, 2020
Sponsor
Oslo University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04571918
Brief Title
Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.
Acronym
AMRIS
Official Title
Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and or Biodegradable Spacer: a Prospective Randomized Clinical Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2020 (Anticipated)
Primary Completion Date
September 1, 2022 (Anticipated)
Study Completion Date
September 1, 2029 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge to the affected patient and its doctor. It is a painful condition with few treatment options. The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far. To this date there is only small and non-randomized studies on the subject. AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group B, the control group are treated with arthroscopic debridement and biceps tenotomy.
Detailed Description
The study is designed as a double blinded randomized controlled trial. The physiotherapist responsible for the clinical testing and the patient are both blinded. The surgeon knows which group the patient is in but is not responsible for any of the testing. We will randomize with envelopes perioperatively. The participants are randomized in hence "ballon" or "not ballon". In advance of the randomization the surgeon will evaluate if the patient is candidate for partial suture before randomization. We plan to stratify the patients with partial suture to ensure homogeneity between the groups. The operation will start with arthroscopic debridement and biceps tenotomy in both groups. The patients are thereby evaluated for partial suture and randomized. The insertion of the subacromial spacer is done at the end of the operation for those patients randomized to the group "balloon". Peroperatively the surgeon will classify the grade of osteoarthritis with Outerbridge classification and the state of the rotator cuff and the long head of the biceps tendon. Postoperative mobilization will be the following: 0-2 weeks: Immobilization in a sling. The participant is advised to do simple exercises for shoulder mobilization. Restriction of movement above shoulder level. 2-6 weeks: Free mobilization. Advised to avoid heavy lifting. 6-12 weeks: Work on increasing range of motion, gradually introduce weight lifting.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Massive Rotator Cuff Tears
Keywords
Ballon spacer, Biodegradable spacer, Subacromial spacer

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
ParticipantOutcomes Assessor
Masking Description
Both participant and physiotherapist who are responsible for the testing will be masked.
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group A: Biodegradable spacer
Arm Type
Experimental
Arm Description
Intervention group
Arm Title
Group B: control group
Arm Type
Active Comparator
Arm Description
Control group
Intervention Type
Procedure
Intervention Name(s)
Biodegradable spacer
Intervention Description
Implantation of a biodegradable balloon used as a subacromial spacer.
Intervention Type
Procedure
Intervention Name(s)
Debridement and biceps tenotomy
Intervention Description
Surgery with arthroscopic debridement and biceps tenotomy
Primary Outcome Measure Information:
Title
Change in Constant score
Description
A well review score that takes several factors in to account: active range of motion, activities of daily living, pain and strength. A person with a normal, healthy shoulder should score 100 points, which is maximum score. Constant score is seen as a relatively objective test, as the testing will be performed by a physiotherapist.
Time Frame
Preop, 6 months, 1 year, 2 years, 5 years, 10 years.
Secondary Outcome Measure Information:
Title
WORC
Description
Western Ontario Rotator Cuff Index is a questionnaire that explores 5 domains: physical symptoms, sports and recreation, work, social function, emotions.
Time Frame
Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years
Title
X-ray of the shoulder
Description
Measure the height from the head of the humerus to the acromion
Time Frame
Preop. Postop: 1. day, 1 year, 2 years, 5 years, 10 years
Title
VAS
Description
Visual analog scale for pain in rest, activity and at night. Scale from 0 til 10.
Time Frame
Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years
Title
Eq-5D
Description
Questionaire for daily activity
Time Frame
Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs classification. Persistent pain for at least 3 months, with documented failure of conservative treatment Age ranging from 60 years of age to 85 years of age Exclusion Criteria: Significant shoulder osteoarthritis in the affected shoulder, Hamada classification >2. Total rupture of subscapularis tendon and/or teres minor, classified B and E in the Collins classification. Comorbidity to the degree that the patient will not be able to participate in the follow up program.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hannah Ugletveit Jahr, Cand. med.
Phone
+47 90762377
Email
hannah.jahr@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Berte Bøe, PhD
Phone
+47 41338451
Email
uxbebm@ous-hf.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hannah Ugletveit Jahr, Cand. med
Organizational Affiliation
Hospital of southern Norway
Official's Role
Study Director
Facility Information:
Facility Name
Hospital of Southern Norway, Arendal
City
Arendal
ZIP/Postal Code
4848
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hannah U. Jahr, Cand.med
Phone
+4790762377
Email
hannahuj@sshf.no
First Name & Middle Initial & Last Name & Degree
Marek W Zegzdryn, cand.med
Phone
+4791143329
Email
marek.walerian.zegzdryn@sshf.no
Facility Name
Oslo university hospital
City
Oslo
ZIP/Postal Code
0424
Country
Norway
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Berte Bøe, PhD
Phone
+4741338451
Email
uxbebm@ous-hf.no
First Name & Middle Initial & Last Name & Degree
Ragnhild Støen, PhD
Email
stox@ous.hf.no

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
To ensure anonymization of participants, there is no plan to share individual data.

Learn more about this trial

Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.

We'll reach out to this number within 24 hrs